ABBOTT LABORATORIES - Common Stock (ABT)

Historical Holders from Q1 2014 to Q3 2025

Symbol
ABT on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
1.74B
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1.35B
Holdings value
$181B
% of all portfolios
0.143%
Grand Portfolio weight change
-0.004%
Number of holders
3122
Number of buys
1311
Number of sells
-1440
Average Value change %
0%
Average buys %
+0.009%
Average sells %
-0.012%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ABBOTT LABORATORIES - Common Stock (ABT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10.05% $22.2B 175M The Vanguard Group 28 Nov 2025

Institutional Holders of ABBOTT LABORATORIES - Common Stock (ABT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.35B $181B -$2.76B $133.94 3,122
2025 Q2 1.37B $187B +$3.69B $136.01 3,150
2025 Q1 1.35B $179B +$458M $132.65 3,135
2024 Q4 1.35B $152B +$4.6B $113.11 3,033
2024 Q3 1.3B $148B -$1.72B $114.01 2,874
2024 Q2 1.32B $137B +$2.14B $103.91 2,843
2024 Q1 1.3B $148B -$186M $113.66 2,884
2023 Q4 1.3B $144B +$703M $110.07 2,868
2023 Q3 1.3B $126B -$512M $96.85 2,664
2023 Q2 1.3B $142B -$239M $109.02 2,714
2023 Q1 1.3B $132B +$456M $101.26 2,685
2022 Q4 1.3B $142B -$88.1M $109.79 2,741
2022 Q3 1.3B $125B +$341M $96.76 2,596
2022 Q2 1.29B $141B +$1.29B $108.65 2,676
2022 Q1 1.29B $153B -$1.35B $118.36 2,744
2021 Q4 1.3B $183B -$1.04B $140.74 2,792
2021 Q3 1.3B $154B -$489M $118.13 2,518
2021 Q2 1.31B $152B -$1.38B $115.93 2,492
2021 Q1 1.32B $158B +$1.63B $119.84 2,510
2020 Q4 1.31B $143B +$331M $109.49 2,473
2020 Q3 1.31B $142B -$6.98M $108.83 2,293
2020 Q2 1.3B $119B -$1.43B $91.43 2,237
2020 Q1 1.32B $104B -$475M $78.91 2,118
2019 Q4 1.32B $115B +$583M $86.86 2,181
2019 Q3 1.32B $110B -$173M $83.67 2,020
2019 Q2 1.32B $111B +$1.88B $84.10 2,003
2019 Q1 1.31B $105B -$611M $79.94 1,992
2018 Q4 1.32B $95.6B +$1.89B $72.33 1,962
2018 Q3 1.29B $94.8B +$3B $73.36 1,856
2018 Q2 1.25B $76.5B -$964M $60.99 1,801
2018 Q1 1.27B $76.4B +$369M $59.92 1,796
2017 Q4 1.27B $72.3B -$422M $57.07 1,746
2017 Q3 1.27B $67.9B +$614M $53.36 1,591
2017 Q2 1.26B $61.4B +$809M $48.61 1,569
2017 Q1 1.25B $55.6B +$10.5B $44.41 1,585
2016 Q4 1.11B $42.5B +$408M $38.41 1,514
2016 Q3 1.09B $46.1B +$1.15B $42.29 1,484
2016 Q2 1.07B $42B +$1.7B $39.31 1,467
2016 Q1 1.02B $42.8B -$173M $41.83 1,457
2015 Q4 1.03B $46.2B -$497M $44.91 1,498
2015 Q3 1.04B $41.7B +$275M $40.22 1,452
2015 Q2 1.03B $50.8B +$294M $49.08 1,478
2015 Q1 1.03B $47.7B -$625M $46.33 1,463
2014 Q4 1.04B $47B +$448M $45.02 1,472
2014 Q3 1.03B $42.8B +$363M $41.59 1,388
2014 Q2 1.02B $41.7B +$96.9M $40.90 1,377
2014 Q1 1.02B $39.3B -$1.24B $38.51 1,367